ClinicalTrials.gg
Not yet recruitingNCT07784868Updated Aug 25, 2026

Effect of Verbal De-Escalation-Based Simulation on Agitation Management, Perception of Aggression, and Impact of Aggression in Emergency Department Nurses

An interventional study of Standard Verbal De-Escalation Training and Verbal De-Escalation-Based Simulation Training in Agitation Management, Aggression and Verbal De-Escalation, sponsored by Uskudar University. Not yet recruiting at 1 site in Turkey (Türkiye). Per ClinicalTrials.gov, last updated 2026-08-25.

Sponsored by Uskudar University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
78
Allocation
Randomized
Sex
All
01

Study summary

This mixed-methods randomized controlled study aims to evaluate the effects of verbal de-escalation-based simulation training on emergency department nurses' knowledge of agitation management, perceptions of aggression, and the extent to which they are affected by aggressive and violent behaviors. A total of 78 emergency department nurses will be randomly assigned to an intervention group (n=39) or a control group (n=39). Both groups will receive the same standard training program on verbal de-escalation-based agitation management. After the standard training, the intervention group will participate in standardized patient simulation and debriefing sessions. Outcomes will be assessed before the intervention, after the intervention, and at a three-month follow-up. In addition, focus group interviews will be conducted with participants in the intervention group at the three-month follow-up to explore their experiences with the simulation-based training.

02

Conditions studied

  • Agitation Management
  • Aggression
  • Verbal De-Escalation

Browse trials for

Keywords

  • Verbal De-Escalation
  • Agitation Management
  • Aggression
  • Simulation Training
  • Patient Simulation
  • Nurses
  • Emergency Nursing
  • Aggression Perception
  • Impact of Aggression
03

In context

Aggression

248 studies on the registry are indexed under Aggression; 41 are open to participants now.

This study's planned enrollment of 78 is close to the median of 80 across 221 interventional studies indexed under Aggression.

Browse Aggression studies →

Lead sponsor

Uskudar University is the lead sponsor of 170 studies on the registry; 36 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Working as a nurse in the adult emergency department of the hospital where the study will be conducted
  • Working full-time as a nurse
  • Willing to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Being on leave or otherwise unable to work during the study period
  • Having previously received simulation-based training on verbal de-escalation
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
78 participants (estimated)

Study arms

  • Experimental
    Intervention Group

    Participants in this arm will receive the standard training program on verbal de-escalation-based agitation management, followed by standardized patient simulation and debriefing sessions.

    Behavioral: Standard Verbal De-Escalation Training · Behavioral: Verbal De-Escalation-Based Simulation Training

  • Active comparator
    Control Group

    Participants in this arm will receive the standard training program on verbal de-escalation-based agitation management.

    Behavioral: Standard Verbal De-Escalation Training

Interventions

  • BehavioralStandard Verbal De-Escalation Training

    Participants will receive a five-session standard training program on verbal de-escalation-based agitation management. The program covers recognition of agitation and aggression, perceptions and interpretation of aggression, assessment and safe management of the agitated patient, verbal de-escalation principles and techniques, and approaches to protect and strengthen nurses' well-being.

  • BehavioralVerbal De-Escalation-Based Simulation Training

    Following the standard training, participants in the intervention group will take part in a standardized patient simulation involving an agitated patient. The simulation includes prebriefing, scenario-based practice, and structured debriefing based on the PEARLS framework. A structured observation form will be used to provide feedback during debriefing and will not be used as an outcome measure.

06

What researchers measure

Primary outcomes

  1. Change in Agitation Management Knowledge Test Score

    Agitation management knowledge will be assessed using the researcher-developed Agitation Management Knowledge Test. The test consists of 25 items with three response options: True, False, and Don't Know. Total scores range from 0 to 100, with higher scores indicating greater knowledge of agitation management and verbal de-escalation.

    Time frame: Baseline; immediately after completion of the simulation and debriefing sessions in the intervention group (with the control group assessed at the corresponding time point); and 3 months after completion of the intervention period.

  2. Change in Functional Perception of Aggression Score

    Functional perception of aggression will be assessed using the functional subscale of the Perception of Aggression Scale (POAS). The POAS consists of 29 items rated on a 5-point Likert scale. The functional subscale consists of 12 items. The mean subscale score is calculated by dividing the sum of the item scores by the number of items in the subscale and ranges from 1 to 5. Higher scores indicate a greater tendency to perceive aggression as functional, acceptable, and a healthy response.

    Time frame: Baseline; immediately after completion of the simulation and debriefing sessions in the intervention group (with the control group assessed at the corresponding time point); and 3 months after completion of the intervention period.

  3. Change in Dysfunctional Perception of Aggression Score

    Dysfunctional perception of aggression will be assessed using the dysfunctional subscale of the Perception of Aggression Scale (POAS). The POAS consists of 29 items rated on a 5-point Likert scale. The dysfunctional subscale consists of 17 items. The mean subscale score is calculated by dividing the sum of the item scores by the number of items in the subscale and ranges from 1 to 5. Higher scores indicate a greater tendency to perceive aggression as dysfunctional, unacceptable, and undesirable.

    Time frame: Baseline; immediately after completion of the simulation and debriefing sessions in the intervention group (with the control group assessed at the corresponding time point); and 3 months after completion of the intervention period.

  4. Change in Impact of Patient Aggression Score

    Impact of patient aggression will be assessed using the Impact of Patient Aggression on Carers Scale (IMPACS). The scale consists of 7 items and two subscales: Corruption of Relation Between Care Provider and Patient and Not Feeling Confident. Total scores range from 7 to 35, with higher scores indicating a greater negative impact of patient aggression.

    Time frame: Baseline; immediately after completion of the simulation and debriefing sessions in the intervention group (with the control group assessed at the corresponding time point); and 3 months after completion of the intervention period.

Secondary outcomes

  1. Perceived Simulation Effectiveness Score

    Perceived simulation effectiveness will be assessed using the Modified Simulation Effectiveness Tool (SET-M) in the intervention group. The scale consists of 19 items and four subscales: prebriefing, learning, confidence, and debriefing. Total scores range from 19 to 95, with higher scores indicating a more positive perception of the effectiveness of the simulation-based learning experience.

    Time frame: Immediately after completion of the debriefing session following the simulation.

Other outcomes

  1. Qualitative Themes From Semi-Structured Focus Group Interviews on Verbal De-Escalation-Based Simulation Training

    Participants' experiences with the verbal de-escalation-based simulation training will be examined through focus group interviews using researcher-developed semi-structured interview questions. Interview transcripts will be analyzed using content analysis, and the findings will be reported as qualitative themes. The interviews will address perceived changes in knowledge and skills, transfer of knowledge and skills to clinical practice, perceptions of and emotional responses to agitated patients, and maintenance of training effects in clinical practice.

    Time frame: 3 months after the intervention.

07

Study locations

1 site
  • Public Hospital
    Bursa, Bursa 16000, Turkey (Türkiye)
    • Şeyma Erkuş, PhD Student · Contactseymaaerkuss@gmail.com · +90 537 065 9268
    • Şeyma Erkuş, PhD Student · Principal investigator
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared due to participant privacy and confidentiality considerations.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Feb 2027, 4 months later.

Of 93 non-industry interventional studies with no phase under Aggression, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 52. This study's planned 4 months is below that.

Counting every sponsor, half of 93 studies reached it within 22 months; a quarter within 13 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 17, 2026
First posted
Aug 25, 2026
StartEst.
Oct 2026
Primary completionEst.
Feb 2027
CompletionEst.
Feb 2027
Last update
Aug 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07784868
Lead sponsor
Uskudar University
Responsible party
Şeyma Erkuş (Principal Investigator, Uskudar University) — Principal investigator
First posted
Aug 25, 2026
Start date
Oct 2026 (estimated)
Primary completion
Feb 2027 (estimated)
Completion
Feb 2027 (estimated)
Last update
Aug 25, 2026

Study contacts

Şeyma Erkuş, PhD Student
Contact
seymaaerkuss@gmail.com
+90 537 065 92 68
Elçin Babaoğlu Gülseven, Assoc. Prof. Dr.
Contact
elcin.babaoglu@uskudar.edu.tr
+90 552 541 70 69
Elçin Babaoğlu Gülseven, Assoc. Prof. Dr.
study director · Uskudar University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion